|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.70 USD | +0.96% |
|
+13.04% | +9.94% |
| 09/02 | Barclays Adjusts Price Target on Fortive to $63 From $56, Maintains Equalweight Rating | MT |
| 06/02 | BNP Paribas Adjusts Price Target on Fortive to $58 From $50, Maintains Neutral Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 463.44Cr | 525.47Cr | 582.57Cr | 606.53Cr | 623.18Cr | |||||
Total Revenues | 463.44Cr | 525.47Cr | 582.57Cr | 606.53Cr | 623.18Cr | |||||
Cost of Goods Sold, Total | 201.77Cr | 224.48Cr | 246.23Cr | 247.12Cr | 250.08Cr | |||||
Gross Profit | 261.67Cr | 300.99Cr | 336.34Cr | 359.41Cr | 373.1Cr | |||||
Selling General & Admin Expenses, Total | 166.22Cr | 176.69Cr | 193.54Cr | 206.55Cr | 217.41Cr | |||||
R&D Expenses | 32Cr | 35Cr | 40Cr | 40Cr | 41Cr | |||||
Other Operating Expenses, Total | 198.29Cr | 212.17Cr | 233.69Cr | 246.33Cr | 258.81Cr | |||||
Operating Income | 63Cr | 89Cr | 102.65Cr | 113.08Cr | 114.29Cr | |||||
Interest Expense, Total | -15Cr | -10Cr | -9.83Cr | -12Cr | -15Cr | |||||
Net Interest Expenses | -15Cr | -10Cr | -9.83Cr | -12Cr | -15Cr | |||||
Income (Loss) On Equity Invest. | -40L | -1.1Cr | - | - | - | |||||
Other Non Operating Income (Expenses) | 40L | -9L | -1.6Cr | -1.65Cr | -5.8Cr | |||||
EBT, Excl. Unusual Items | 49Cr | 77Cr | 91Cr | 99Cr | 93Cr | |||||
Restructuring Charges | -2.68Cr | -1.87Cr | -1.79Cr | - | - | |||||
Merger & Related Restructuring Charges | -7Cr | -5.89Cr | -2.08Cr | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 111.92Cr | 5.7Cr | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | 3.75Cr | |||||
Legal Settlements | - | 2.99Cr | - | - | - | |||||
Other Unusual Items | - | -10Cr | - | - | - | |||||
EBT, Incl. Unusual Items | 150.77Cr | 68Cr | 87Cr | 99Cr | 97Cr | |||||
Income Tax Expense | 5.55Cr | 6.33Cr | 12Cr | 12Cr | 14Cr | |||||
Earnings From Continuing Operations | 145.22Cr | 61Cr | 76Cr | 87Cr | 83Cr | |||||
Earnings Of Discontinued Operations | 16Cr | -58L | - | - | - | |||||
Net Income to Company | 161.33Cr | 61Cr | 76Cr | 87Cr | 83Cr | |||||
Net Income - (IS) | 161.33Cr | 61Cr | 76Cr | 87Cr | 83Cr | |||||
Preferred Dividend and Other Adjustments | 6.9Cr | 3.45Cr | - | - | - | |||||
Net Income to Common Incl Extra Items | 154.43Cr | 57Cr | 76Cr | 87Cr | 83Cr | |||||
Net Income to Common Excl. Extra Items | 138.32Cr | 58Cr | 76Cr | 87Cr | 83Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.58 | 1.64 | 2.12 | 2.46 | 2.39 | |||||
Basic EPS - Continuing Operations | 4.1 | 1.66 | 2.12 | 2.46 | 2.39 | |||||
Basic Weighted Average Shares Outstanding | 34Cr | 35Cr | 36Cr | 35Cr | 35Cr | |||||
Net EPS - Diluted | 4.49 | 1.63 | 2.1 | 2.43 | 2.36 | |||||
Diluted EPS - Continuing Operations | 4.05 | 1.65 | 2.1 | 2.43 | 2.36 | |||||
Diluted Weighted Average Shares Outstanding | 36Cr | 35Cr | 36Cr | 36Cr | 35Cr | |||||
Normalized Basic EPS | 0.9 | 1.38 | 1.6 | 1.76 | 1.67 | |||||
Normalized Diluted EPS | 0.84 | 1.37 | 1.58 | 1.74 | 1.65 | |||||
Dividend Per Share | 0.28 | 0.28 | 0.28 | 0.29 | 0.32 | |||||
Payout Ratio | 10.13 | 21.73 | 13.18 | 11.78 | 13.35 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 101.78Cr | 128.37Cr | 149.21Cr | 158.76Cr | 168.68Cr | |||||
EBITA | 94Cr | 120.9Cr | 140.86Cr | 150.12Cr | 159.62Cr | |||||
EBIT | 63Cr | 89Cr | 102.65Cr | 113.08Cr | 114.29Cr | |||||
EBITDAR | 107.78Cr | 134.37Cr | 154.81Cr | 163.66Cr | 173.78Cr | |||||
Total Revenues (As Reported) | 463.44Cr | 525.47Cr | 582.57Cr | 606.53Cr | 623.18Cr | |||||
Effective Tax Rate - (Ratio) | 3.68 | 9.34 | 13.54 | 12.62 | 14.1 | |||||
Current Domestic Taxes | 7.88Cr | 2.93Cr | 9.51Cr | 13Cr | 6.34Cr | |||||
Current Foreign Taxes | 7.43Cr | 7.5Cr | 8.53Cr | 9.73Cr | 14Cr | |||||
Total Current Taxes | 15Cr | 10Cr | 18Cr | 23Cr | 20Cr | |||||
Deferred Domestic Taxes | -6.46Cr | -2.41Cr | -7.07Cr | -8.08Cr | -5.3Cr | |||||
Deferred Foreign Taxes | -3.3Cr | -1.69Cr | 86L | -2.33Cr | -1.2Cr | |||||
Total Deferred Taxes | -9.76Cr | -4.1Cr | -6.21Cr | -10Cr | -6.5Cr | |||||
Normalized Net Income | 30Cr | 48Cr | 57Cr | 62Cr | 58Cr | |||||
Interest on Long-Term Debt | 5.4Cr | 4.5Cr | 21L | - | - | |||||
Non-Cash Pension Expense | 24L | 22L | -4L | 29L | 6L | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 32Cr | 35Cr | 40Cr | 40Cr | 41Cr | |||||
Net Rental Expense, Total | 6Cr | 6Cr | 5.6Cr | 4.9Cr | 5.1Cr | |||||
Imputed Operating Lease Interest Expense | 1.3Cr | 1.16Cr | 1.16Cr | 1.34Cr | 1.62Cr | |||||
Imputed Operating Lease Depreciation | 4.7Cr | 4.84Cr | 4.44Cr | 3.56Cr | 3.48Cr | |||||
Stock-Based Comp., SG&A Exp. (Total) | 6.26Cr | 7.74Cr | 9.38Cr | 11Cr | 11Cr | |||||
Total Stock-Based Compensation | 6.26Cr | 7.74Cr | 9.38Cr | 11Cr | 11Cr |
- Stock Market
- Equities
- FTV Stock
- Financials Fortive Corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















